Table of Content


Introduction
Hospital Acquired Pneumonia (HAP) - Overview
Hospital Acquired Pneumonia (HAP) - Therapeutics Development
Hospital Acquired Pneumonia (HAP) - Therapeutics Assessment
Hospital Acquired Pneumonia (HAP) - Companies Involved in Therapeutics Development
Hospital Acquired Pneumonia (HAP) - Drug Profiles
Hospital Acquired Pneumonia (HAP) - Dormant Projects
Hospital Acquired Pneumonia (HAP) - Discontinued Products
Hospital Acquired Pneumonia (HAP) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Hospital Acquired Pneumonia (HAP), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Hospital Acquired Pneumonia (HAP), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Products under Development by Companies, H2 2020 (Contd..3), H2 2020
Products under Development by Companies, H2 2020 (Contd..4), H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Antabio SAS, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Aridis Pharmaceuticals Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by AstraZeneca Plc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Auspherix Pty Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Biolytx Pharmaceuticals Corp, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Bioversys AG, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Centauri Therapeutics Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Clarametyx Biosciences Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Cumberland Pharmaceuticals Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by CytaCoat AB, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Destiny Pharma Plc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Dong-A Socio Holdings Co Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by EnBiotix Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Helperby Therapeutics Group Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Hypo-Stream Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by La Jolla Pharmaceutical Company, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Meiji Seika Pharma Co Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Merck & Co Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Motif Bio Plc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Nabriva Therapeutics Plc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Nosopharm SAS, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Omnix Medical Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Peptineo, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Polyphor AG, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Pulmobiotics SL, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Qilu Pharmaceutical Co Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Sealife PHARMA GMBH, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Shionogi & Co Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Spero Therapeutics Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by TGV-Inhalonix Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by VenatoRx Pharmaceuticals Inc, H2 2020
Hospital Acquired Pneumonia (HAP) - Pipeline by Wockhardt Ltd, H2 2020
Hospital Acquired Pneumonia (HAP) - Dormant Projects, H2 2020
Hospital Acquired Pneumonia (HAP) - Dormant Projects, H2 2020 (Contd..1), H2 2020
Hospital Acquired Pneumonia (HAP) - Discontinued Products, H2 2020